Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy

Summary

The purpose of this study is to determine etokimab safety, tolerability and activity in adult participants with peanut allergy.

Timeline

Start

2017-01-26

Primary completion

2018-03-30

Completion

2018-03-30

Publications

• Results Chinthrajah S, Cao S, Liu C, Lyu SC, Sindher SB, Long A, Sampath V, Petroni D, Londei M, Nadeau KC. Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy. JCI Insight. 2019 Nov 14;4(22):e131347. doi: 10.1172/jci.insight.131347.

Drugs

Indications